Results 211 to 220 of about 4,264,159 (300)

Inter-neural co-regulation before and after an interactive perturbation in mother-infant dyads. [PDF]

Sci Rep
Capelli E, Provenzi L, Pili MP, Riva V, Billeci L, Cremaschi G, D'Alfonso S, Günay Y, Roberti E, Borgatti R.   +9 more
europepmc   +1 more source

Revisiting Mission‐Oriented Cancer Research to tackle the increasing burden of cancer in Europe–a policy perspective

Molecular Oncology, EarlyView.
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor, Julio Celis, Ulrik Ringborg   +2 more
wiley   +1 more source

Affective touch and face recognition: effects on memory and metacognitive performance. [PDF]

Sci Rep
Bregulla M, Packheiser J, Merz CJ, Echterhoff G, Scheele D.   +4 more
europepmc   +1 more source

Insights into a long life without cancer: The case of the bowhead whale

Molecular Oncology, EarlyView.
Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley   +1 more source

Working face status detection in coal mine based on YOLOv8-EST. [PDF]

Sci Rep
Wang H, Wu G, Yang Q, Huang Y, Lv Z, Yang J.   +5 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Efficacy of a Conversational AI Agent for Psychiatric Symptoms and Digital Therapeutic Alliance: A Randomized Clinical Trial.

JAMA Netw Open
Shoshani A, Gurfinkel B, Kor A, Ben-Haim Y, Kanarek O, Segev R, Shafir O, Arbel R.   +7 more
europepmc   +1 more source

Motion aftereffects from viewing another's gaze are restricted to the line of sight. [PDF]

Front Hum Neurosci
Renet C, Löfström R, Randall W, Guterstam A.   +3 more
europepmc   +1 more source

Positive Face and Negative Face in Chinese and Japanese

Lecture Notes on Language and Literature
openaire   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source